A new class of drugs to tackle AMR - immuno-antibiotics
Science Daily - 23-Dec-2020Block an essential metabolic pathway in bacteria to combat antimicrobial resistance (AMR)
Join the club for FREE to access the whole archive and other member benefits.
Assistant professor in the Vaccine & Immunotherapy Center at The Wistar Institute
Dotiwala studies the mechanisms by which cell-based innate and adaptive immunity destroy diverse non-viral pathogens, with the aim of applying these mechanistic insights to aid in designing better antimicrobial and anti-cancer therapies.
Dotiwala received an M.B.B.S. in Medicine from Grant Medical College, Mumbai, India, and a Ph.D. in Molecular and Cell Biology from Brandeis University. He was a postdoctoral research fellow at Harvard University and an Instructor in Pediatrics at Boston Children’s Hospital and Harvard Medical School, before joining Wistar as an assistant professor in 2017.
Visit website: https://wistar.org/our-scientists/farokh-dotiwala
See also: The Wistar Institute - Independent institution devoted to biomedical research and training
Details last updated 10-Jan-2021
Block an essential metabolic pathway in bacteria to combat antimicrobial resistance (AMR)